Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04817007
Brief Title: A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

First Submitted : March 18, 2021
First Submitted that Met QC Criteria : March 24, 2021
First Posted : March 25, 2021

Last Update Submitted that Met QC Criteria : August 1, 2022
Last Update Posted : August 3, 2022